| Page 1113 | Kisaco Research
 

Sneha Narahalli

Head of Product (Digital, Data & MarTech)
Sephora

Sneha Narahalli

Head of Product (Digital, Data & MarTech)
Sephora

Sneha Narahalli

Head of Product (Digital, Data & MarTech)
Sephora
 

Agustina Sartori

Senior Director Innovation & Innovation Fund
Ulta

Agustina Sartori is the Sr Director of Innovation Experiences & the Managing Director of Prisma Ventures, the technology fund of ULTA Beauty. She joined Ulta Beauty in 2018 after the company’s acquisition of GlamST, the company she was CEO and Founder,  to help develop AR experiences that combine augmented reality, artificial intelligence, and machine learning technologies such as GLAMLab.

Agustina Sartori

Senior Director Innovation & Innovation Fund
Ulta

Agustina Sartori

Senior Director Innovation & Innovation Fund
Ulta

Agustina Sartori is the Sr Director of Innovation Experiences & the Managing Director of Prisma Ventures, the technology fund of ULTA Beauty. She joined Ulta Beauty in 2018 after the company’s acquisition of GlamST, the company she was CEO and Founder,  to help develop AR experiences that combine augmented reality, artificial intelligence, and machine learning technologies such as GLAMLab. In her dual role at Digital Innovation, she leads a team of engineers, designers, and beauty enthusiasts that develops and experiments with guest-facing emerging technologies to create differentiated guest experiences. She also Managing Director of the newly launched Prisma Ventures. The fund officially launched mid 2022, a Venture Fund, to invest in early-stage startups in the retail technology space. A San Francisco resident, Agustina is originally from Uruguay where she received her Telematics Engineering degree from the University of Montevideo. Throughout her career, she has successfully raised significant capital, went through 500 Startups, Startup Chile and Plug and Play, is an Endeavor entrepreneur, and worked with world-class brands such as L’Oreal, Estee Lauder, Dufry, Clarins, and Neiman Marcus, among others. 

 

Carolina Reis Oliveria

Co-Founder & CEO
OneSkin

Carolina Reis Oliveria

Co-Founder & CEO
OneSkin

Carolina Reis Oliveria

Co-Founder & CEO
OneSkin
 

Claire Chang

General Partner
ignite XL Ventures

Having immigrated from Korea to the US when she was 12 years old, Claire is bilingual and bicultural, which has always given her the unique perspective of being both an insider and outsider able to bridge different perspectives.  Combining her passions for connecting people and helping them realize their dreams, Claire launched a global accelerator in 2014 which impacted over 200 Korean startups' ability to expand to the US market.  In 2018, Claire launched 

Claire Chang

General Partner
ignite XL Ventures

Claire Chang

General Partner
ignite XL Ventures

Having immigrated from Korea to the US when she was 12 years old, Claire is bilingual and bicultural, which has always given her the unique perspective of being both an insider and outsider able to bridge different perspectives.  Combining her passions for connecting people and helping them realize their dreams, Claire launched a global accelerator in 2014 which impacted over 200 Korean startups' ability to expand to the US market.  In 2018, Claire launched SVBeautyTech, the first-ever independent beauty-tech accelerator, to provide a cohort of mostly female beauty-tech founders access to the Silicon Valley resources previously enjoyed almost exclusively by male, locally networked tech entrepreneurs.  Leveraging her global accelerator network and broad brand connections, Claire is excited to work with passionate innovators and disruptors working at the intersection of technology, beauty & wellness.

igniteXL Venturs is a Silicon Valley-based global seed fund investing in game-changing entrepreneurs at the intersection of technology, beauty and wellness.   With the advancement of technology and the rise of conscious consumers who demand authenticity, sustainability, transparency, and inclusivity, the wellness industry is undergoing digital and cultural transformation. And that transformation represents excellent investment opportunities to investors with high margins, recurring and engaged customers, with attractive exit opportunities. 

 

Osmaan Shah

Founder & CEO
Formulate

Osmaan is the founder and CEO of Formulate, a customization manufacturing platform and consumer brand that offers personalized hair, scalp, and skin care products.

Osmaan Shah

Founder & CEO
Formulate

Osmaan Shah

Founder & CEO
Formulate

Osmaan is the founder and CEO of Formulate, a customization manufacturing platform and consumer brand that offers personalized hair, scalp, and skin care products.

 

Tomasz Rygiel

Co-founder & Member of the Board
Cellis

Tomasz Rygiel

Co-founder & Member of the Board
Cellis

Tomasz Rygiel

Co-founder & Member of the Board
Cellis
 

Kiran Sonaje

Head, R&D
Advamedica

Kiran Sonaje

Head, R&D
Advamedica

Kiran Sonaje

Head, R&D
Advamedica
 

Mariann Micsinai-Balan

Vice President, Head of Data Science and Statistical Methodology
Bristol Myers Squibb

Mariann Micsinai-Balan

Vice President, Head of Data Science and Statistical Methodology
Bristol Myers Squibb

Mariann Micsinai-Balan

Vice President, Head of Data Science and Statistical Methodology
Bristol Myers Squibb
 

Fia Navntoft

Senior Clinical Project Manager
Mölnlycke Healthcare

Fia Navntoft

Senior Clinical Project Manager
Mölnlycke Healthcare

Fia Navntoft

Senior Clinical Project Manager
Mölnlycke Healthcare
 

Leo Mavely

Founder and Chief Executive Officer
AXIO Biosolutions

Leo Mavely is the CEO of Axio Biosolutions a medtech company focused on novel

biomaterials for advanced wound care and surgical solutions. Axiostat® its flagship product

which was developed to reduce the mortality due to traumatic bleeding from life threatening

injuries and is approved in over 45 countries and used by major armed forces globally. Their

more recent offering, Maxiocel is a 100% chitosan based advanced woundcare platform that

is CE marked and now used across Europe.

Leo Mavely

Founder and Chief Executive Officer
AXIO Biosolutions

Leo Mavely

Founder and Chief Executive Officer
AXIO Biosolutions

Leo Mavely is the CEO of Axio Biosolutions a medtech company focused on novel

biomaterials for advanced wound care and surgical solutions. Axiostat® its flagship product

which was developed to reduce the mortality due to traumatic bleeding from life threatening

injuries and is approved in over 45 countries and used by major armed forces globally. Their

more recent offering, Maxiocel is a 100% chitosan based advanced woundcare platform that

is CE marked and now used across Europe.

A bioengineer by qualification, Leo invented the core technology of Axio and is passionate

about building affordable healthcare products. Leo holds multiple patents and publications in

the field of novel biomaterials for medical tech applications.

Leo was featured in the list of 40 under 40 emerging business leaders by Fortune Magazine

consecutively in 2016, 2017, 2018 and 2019 and in the list of 35 under 35 entrepreneurs by

Entrepreneur magazine in 2020. He was the recipient of Silicon valley challenge 2014,

Anjani Mashelkar Inclusive Innovation Award 2013, CNBC Samsung Social Innovation

Award 2012 and was invited speaker at Indian Science congress 2010.

Axio has raised over $20mn in venture funding from Accel Partners, Ratan Tata’s UC-RNT

Fund, Omidyar network, Chiratate venture and TrueScale capital. Axio has its state of the art

R&D and manufacturing facility in India and is head quartered in Cambridge, USA.